Clinical Trial Update: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating Mircera for anemia in patients with non-small cell lung cancer receiving first-line chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Non-small Cell Lung Cancer

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 2 | Status: COMPLETED